Xtl Biopharmaceuticals (XTLB) EPS (Diluted) Growth (3y) (2012 - 2024)
Xtl Biopharmaceuticals (XTLB) EPS (Diluted) Growth (3y) (2012 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 78.99% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 37.28% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.39% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -2.00% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 83.94% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Xtl Biopharmaceuticals | 2.60 Bn | 2.60 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -188.96% |
| Sep 30, 2024 | 62.54% |
| Jun 30, 2024 | -37.38% |
| Mar 31, 2024 | 17.94% |
| Dec 31, 2023 | -8,461.42% |
| Sep 30, 2023 | 5,649.44% |
| Jun 30, 2023 | -6,903.35% |
| Dec 31, 2022 | -0.20% |
| Sep 30, 2022 | -4,241.93% |
| Jun 30, 2022 | -3,176.87% |
| Mar 31, 2022 | 1,772.84% |
| Dec 31, 2021 | 57.60% |
| Sep 30, 2021 | -6,815.81% |
| Mar 31, 2021 | 4,684.01% |
| Dec 31, 2020 | 95.79% |
| Sep 30, 2020 | 0.63% |
| Jun 30, 2020 | -36.04% |
| Dec 31, 2019 | -6,462.32% |
| Sep 30, 2019 | -25.99% |
| Jun 30, 2019 | -44.22% |